Mark Bonyhadi
Directeur/Membre du Conseil chez TC BIOPHARM (HOLDINGS) PLC
Fortune : - $ au 30/11/2023
Postes actifs de Mark Bonyhadi
Sociétés | Poste | Début | Fin |
---|---|---|---|
TC BIOPHARM (HOLDINGS) PLC | Directeur/Membre du Conseil | 22/02/2022 | - |
Independent Dir/Board Member | 22/02/2022 | - |
Historique de carrière de Mark Bonyhadi
Anciens postes connus de Mark Bonyhadi
Sociétés | Poste | Début | Fin |
---|---|---|---|
Qiming US Ventures Management, LLC
Qiming US Ventures Management, LLC Investment ManagersFinance Qiming US Ventures Management LLC (Qiming Venture Partners) is a venture capital subsidiary of Qiming Venture Partners Ltd founded in 2017 by Mark D. McDade and Gary Edward Rieschel. The firm is headquartered in Cambridge, Massachusetts. | Consultant / Advisor | 01/12/2018 | 31/12/2022 |
Private Equity Investor | 01/12/2018 | 31/12/2022 | |
Systemix, Inc.
Systemix, Inc. Medical/Nursing ServicesHealth Services Systemix, Inc. develops cell-based gene therapies for diseases. The company is based in Palo Alto, CA. The company was founded by Irving L. Weissman, Leroy E. Hood. Systemix was acquired by Novartis AG on February 14, 1997 for $75.90 million. | Directeur Technique/Scientifique/R&D | - | 12/10/2021 |
JUNO THERAPEUTICS INC | Corporate Officer/Principal | 01/01/2013 | 01/01/2018 |
Life Technologies Ltd.
Life Technologies Ltd. BiotechnologyHealth Technology Life Technologies Ltd. engages in scientific and medical activities. The company was founded on May 13, 1983 and is headquartered in Paisley, the United Kingdom. | Corporate Officer/Principal | 01/01/2006 | 01/01/2013 |
Xcyte Therapies, Inc. | Directeur Technique/Scientifique/R&D | 01/01/1997 | 30/03/2006 |
American Society of Gene & Cell Therapy
American Society of Gene & Cell Therapy Miscellaneous Commercial ServicesCommercial Services The American Society of Gene & Cell Therapy is a medical and professional organization that represents researchers and scientists devoted to the discovery of gene and cell therapies. The American company was founded by Mark A. Kay. | Président | - | - |
Formation de Mark Bonyhadi
The Reed Institute | Undergraduate Degree |
University of California, Berkeley | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 8 |
Royaume-Uni | 3 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 2 |
Corporate Officer/Principal | 2 |
Undergraduate Degree | 1 |
Sectorielle
Health Technology | 5 |
Consumer Services | 3 |
Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
TC BIOPHARM (HOLDINGS) PLC | Health Technology |
Entreprise privées | 6 |
---|---|
Xcyte Therapies, Inc. | Health Technology |
Juno Therapeutics, Inc.
Juno Therapeutics, Inc. BiotechnologyHealth Technology Juno Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of innovative cellular immunotherapy for the treatment of cancer. It offers platforms which includes chimeric antigen receptors and T-cell receptors. The company was founded by Hans Edgar Bishop, Lawrence Corey, Richard D. Klausner, Stan Riddell, Isabelle Riviere, and Robert Taylor Nelsen on August 5, 2013 and is headquartered in Seattle, WA. | Health Technology |
Life Technologies Ltd.
Life Technologies Ltd. BiotechnologyHealth Technology Life Technologies Ltd. engages in scientific and medical activities. The company was founded on May 13, 1983 and is headquartered in Paisley, the United Kingdom. | Health Technology |
Qiming US Ventures Management, LLC
Qiming US Ventures Management, LLC Investment ManagersFinance Qiming US Ventures Management LLC (Qiming Venture Partners) is a venture capital subsidiary of Qiming Venture Partners Ltd founded in 2017 by Mark D. McDade and Gary Edward Rieschel. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Systemix, Inc.
Systemix, Inc. Medical/Nursing ServicesHealth Services Systemix, Inc. develops cell-based gene therapies for diseases. The company is based in Palo Alto, CA. The company was founded by Irving L. Weissman, Leroy E. Hood. Systemix was acquired by Novartis AG on February 14, 1997 for $75.90 million. | Health Services |
American Society of Gene & Cell Therapy
American Society of Gene & Cell Therapy Miscellaneous Commercial ServicesCommercial Services The American Society of Gene & Cell Therapy is a medical and professional organization that represents researchers and scientists devoted to the discovery of gene and cell therapies. The American company was founded by Mark A. Kay. | Commercial Services |
- Bourse
- Insiders
- Mark Bonyhadi
- Expérience